Table 1.
Indications for MRS.
Table 2.
Confirmation of the definitive diagnosis.
Table 3.
Distribution of the definitive diagnoses in the categories.
Table 4.
Outcome of the radiological diagnostics of the lesions.
Comparison between the diagnoses from MRI only and when MRS information was added.
Table 5.
Outcome of the radiological diagnostics in some subcategories.
Table 6.
Distribution of radiological diagnoses to diagnostic categories in cases with a confirmed primary high-grade CNS tumour.
Table 7.
Distribution of radiological diagnoses in cases with a confirmed metastatic disease.
Table 8.
Radiological outcome with the different spectroscopic methods.
Table 9.
Clinical benefit of the added MRS compared to MRI only.